A detailed history of Fort Sheridan Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Fort Sheridan Advisors LLC holds 14,039 shares of ABT stock, worth $1.65 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
14,039
Previous 13,509 3.92%
Holding current value
$1.65 Million
Previous $1.4 Million 14.04%
% of portfolio
0.25%
Previous 0.23%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $53,037 - $62,608
530 Added 3.92%
14,039 $1.6 Million
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $57,919 - $64,653
575 Added 4.45%
13,509 $1.4 Million
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $82,359 - $90,961
752 Added 6.17%
12,934 $1.47 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $895,955 - $1.05 Million
9,250 Added 315.48%
12,182 $1.23 Million
Q3 2022

Nov 09, 2022

SELL
$96.76 - $112.03 $4,063 - $4,705
-42 Reduced 1.41%
2,932 $284,000
Q2 2022

Aug 08, 2022

BUY
$102.07 - $123.37 $99,518 - $120,285
975 Added 48.77%
2,974 $323,000
Q1 2022

May 09, 2022

SELL
$114.02 - $139.04 $54,729 - $66,739
-480 Reduced 19.36%
1,999 $237,000
Q4 2021

Feb 10, 2022

SELL
$115.53 - $141.46 $12,361 - $15,136
-107 Reduced 4.14%
2,479 $349,000
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $50,163 - $55,495
-430 Reduced 14.26%
2,586 $305,000
Q2 2021

Aug 17, 2021

BUY
$105.79 - $124.53 $123,985 - $145,949
1,172 Added 63.56%
3,016 $350,000
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $31,500 - $34,326
-300 Reduced 13.99%
1,844 $202,000
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $28,133 - $34,166
-307 Reduced 12.53%
2,144 $233,000
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $187,673 - $240,198
2,451 New
2,451 $224,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Fort Sheridan Advisors LLC Portfolio

Follow Fort Sheridan Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Sheridan Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Sheridan Advisors LLC with notifications on news.